VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,914,350 | -93.1% | 121,000 | -94.9% | 0.01% | -93.9% |
| Q3 2022 | $57,073,000 | +1650.2% | 2,366,200 | +1886.7% | 0.16% | +1733.3% |
| Q2 2022 | $3,261,000 | -29.0% | 119,100 | -0.6% | 0.01% | -25.0% |
| Q1 2022 | $4,594,000 | +15.3% | 119,800 | -3.7% | 0.01% | +20.0% |
| Q4 2021 | $3,985,000 | +6.8% | 124,400 | -1.7% | 0.01% | 0.0% |
| Q3 2021 | $3,731,000 | -8.8% | 126,600 | +0.6% | 0.01% | -9.1% |
| Q1 2021 | $4,092,000 | -17.4% | 125,900 | -8.4% | 0.01% | -15.4% |
| Q4 2020 | $4,953,000 | +87.9% | 137,500 | +20.2% | 0.01% | +30.0% |
| Q1 2020 | $2,636,000 | +20.4% | 114,400 | +52.9% | 0.01% | +100.0% |
| Q4 2019 | $2,190,000 | -34.9% | 74,800 | -40.6% | 0.01% | -37.5% |
| Q3 2019 | $3,363,000 | +1449.8% | 125,900 | +1381.2% | 0.01% | +700.0% |
| Q2 2019 | $217,000 | -93.0% | 8,500 | -93.9% | 0.00% | -87.5% |
| Q1 2019 | $3,110,000 | – | 138,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |